Blood Cancer Journal - Table of Contents alert Volume 8 October 2018

TABLE OF CONTENTS Volume 8 (October 2018) In this issue Current Treatment Algorithm Article Current Treatment Algorithm Top Chronic lymphocytic leukemia treatment algorithm 2018 Sameer A. Parikh Blood Cancer Journal 2018 8: 10.1038/s41408-018-0131-2 Abstract | Full Text Article Top CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto & Taketo Yamada Blood Cancer Journal 2018 8: 10.1038/s41408-018-0127-y Abstract | Full Text Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens George Z. Rassidakis, Nikolas Herold, Ida Hed Myrberg, Nikolaos Tsesmetzis, Sean G. Rudd et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0134-z Abstract | Full Text Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry Linda B. Baughn, Kathryn Pearce, Dirk Larson, Mei-Yin Polley, Eran Elhaik et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0132-1 Abstract | Full Text Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma Kerstin Wenzl, Michelle K. Manske, Vivekananda Sarangi, Yan W. Asmann, Patricia T. Greipp et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0130-3 Abstract | Full Text Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo Emmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, Lydia Roy, Jerome Rey et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0133-0 Abstract | Full Text Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group Lia A. Moulopoulos, Vassilis Koutoulidis, Jens Hillengass, Elena Zamagni, Jesus D. Aquerreta et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0124-1 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from Blood Cancer Journal click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.